JP2018502860A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502860A5 JP2018502860A5 JP2017536526A JP2017536526A JP2018502860A5 JP 2018502860 A5 JP2018502860 A5 JP 2018502860A5 JP 2017536526 A JP2017536526 A JP 2017536526A JP 2017536526 A JP2017536526 A JP 2017536526A JP 2018502860 A5 JP2018502860 A5 JP 2018502860A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- pharmaceutical formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101190P | 2015-01-08 | 2015-01-08 | |
| US62/101,190 | 2015-01-08 | ||
| PCT/US2016/012650 WO2016112292A1 (en) | 2015-01-08 | 2016-01-08 | Formulation of mk2 inhibitor peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018502860A JP2018502860A (ja) | 2018-02-01 |
| JP2018502860A5 true JP2018502860A5 (https=) | 2019-02-14 |
Family
ID=56356475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536526A Pending JP2018502860A (ja) | 2015-01-08 | 2016-01-08 | Ｍｋ２阻害ペプチド製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10087225B2 (https=) |
| EP (1) | EP3242886A4 (https=) |
| JP (1) | JP2018502860A (https=) |
| KR (1) | KR20170102900A (https=) |
| CN (1) | CN107406489A (https=) |
| AU (1) | AU2016205125A1 (https=) |
| BR (1) | BR112017014737A2 (https=) |
| CA (1) | CA2972916A1 (https=) |
| HK (1) | HK1246807A1 (https=) |
| MX (1) | MX2017008994A (https=) |
| RU (1) | RU2017128077A (https=) |
| SG (1) | SG11201705559RA (https=) |
| WO (1) | WO2016112292A1 (https=) |
| ZA (1) | ZA201704495B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62017B1 (sr) | 2014-09-17 | 2021-07-30 | Celgene Car Llc | Mk2 inhibitori i njihova upotreba |
| US10882867B2 (en) | 2017-03-16 | 2021-01-05 | Celgene Car Llc | Forms and compositions of a MK2 inhibitor |
| WO2019176618A1 (ja) | 2018-03-13 | 2019-09-19 | 株式会社Adeka | 非水電解質二次電池 |
| US20210322310A1 (en) * | 2020-04-16 | 2021-10-21 | Cai Gu Huang | Inhalable Formulation of a Solution Containing Tiotropium Bromide |
| CN111647088B (zh) * | 2020-06-29 | 2023-05-02 | 东北师范大学 | 细胞渗透短肽tat-hns-3及对炎性疾病的应用 |
| EP4464694A4 (en) | 2022-01-14 | 2026-04-01 | Shanghai Hansoh Biomedical Co Ltd | POLYCYCLIC DERIVATIVE CONTAINING PYRIDINE, ITS PREPARATION PROCESS AND ITS USE |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1521000A (en) | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
| US4192309A (en) | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
| US4227522A (en) | 1978-09-05 | 1980-10-14 | Syntex Puerto Rico, Inc. | Inhalation device |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| GB2129691B (en) | 1982-10-08 | 1987-08-05 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| WO2006050247A2 (en) * | 2004-10-29 | 2006-05-11 | Neose Technologies, Inc. | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
| AU2007342674B2 (en) | 2007-01-10 | 2013-09-19 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and uses therefor |
| JP5703466B2 (ja) | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | キナーゼ阻害薬およびその使用 |
| CN102256613B (zh) * | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| CA2744104C (en) | 2008-12-10 | 2017-07-18 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| US9890195B2 (en) | 2009-07-27 | 2018-02-13 | Purdue Research Foundation | MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| US20130115256A1 (en) | 2010-05-24 | 2013-05-09 | Cynthia Lander | Methods for treating or preventing vascular graft failure |
| US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| BR112013026313A8 (pt) * | 2011-04-12 | 2018-01-30 | Moerae Matrix Inc | composições e métodos para prevenir ou tratar doenças, condições ou processos caracterizados por proliferação anormal de fibroblastos e depósito de matriz extracelular |
| US20140072613A1 (en) * | 2012-09-10 | 2014-03-13 | Cynthia Lander | Compositions and Methods for Treating Cutaneous Scarring |
| US9102015B2 (en) * | 2013-03-14 | 2015-08-11 | Siemens Energy, Inc | Method and apparatus for fabrication and repair of thermal barriers |
| AU2014250830A1 (en) * | 2013-04-11 | 2015-11-12 | Vanderbilt University | Polyplexes |
-
2016
- 2016-01-08 EP EP16735478.6A patent/EP3242886A4/en not_active Withdrawn
- 2016-01-08 CA CA2972916A patent/CA2972916A1/en not_active Abandoned
- 2016-01-08 US US14/991,531 patent/US10087225B2/en not_active Expired - Fee Related
- 2016-01-08 WO PCT/US2016/012650 patent/WO2016112292A1/en not_active Ceased
- 2016-01-08 JP JP2017536526A patent/JP2018502860A/ja active Pending
- 2016-01-08 BR BR112017014737A patent/BR112017014737A2/pt not_active Application Discontinuation
- 2016-01-08 HK HK18106201.2A patent/HK1246807A1/zh unknown
- 2016-01-08 CN CN201680005237.6A patent/CN107406489A/zh active Pending
- 2016-01-08 SG SG11201705559RA patent/SG11201705559RA/en unknown
- 2016-01-08 MX MX2017008994A patent/MX2017008994A/es unknown
- 2016-01-08 KR KR1020177021042A patent/KR20170102900A/ko not_active Withdrawn
- 2016-01-08 AU AU2016205125A patent/AU2016205125A1/en not_active Abandoned
- 2016-01-08 RU RU2017128077A patent/RU2017128077A/ru not_active Application Discontinuation
-
2017
- 2017-07-03 ZA ZA2017/04495A patent/ZA201704495B/en unknown
-
2018
- 2018-08-21 US US16/106,504 patent/US20190031730A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502860A5 (https=) | ||
| Jiang et al. | Bioinspired design of mannose-decorated globular lysine dendrimers promotes diabetic wound healing by orchestrating appropriate macrophage polarization | |
| ES2476842T3 (es) | Inhibidores polipept�dicos de HSP27 quinasa y usos de los mismos | |
| AU2020280993B2 (en) | Compositions and methods of using islet neogenesis peptides and analogs thereof | |
| RU2743431C2 (ru) | Липосомы, содержащие проникающие в клетки пептиды и тетраэфирные липиды, для пероральной доставки макромолекул | |
| EP2402364B1 (en) | A nonapeptide with anti-tumour activity | |
| JP2014533235A5 (https=) | ||
| US20240051997A1 (en) | Sap and peptidomimetic compositions for reducing symptoms of inflammation | |
| CN102643339B (zh) | 一种glp-1类似物、制备方法及其应用 | |
| CN106456707B (zh) | 干粉肽药剂 | |
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| JP2020518287A5 (https=) | ||
| JP7751641B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| RU2017128077A (ru) | Составы, содержащие пептиды, ингибирующие мк2 | |
| US11571455B2 (en) | Methods and compositions for treating alcoholic liver disease | |
| JP2023547405A (ja) | Ｃａｓ９－ＲＮＰ及び他の核タンパク質カーゴの形質導入のために適合された最小長のシャトル剤ペプチド及びそのバリアント | |
| KR20230121823A (ko) | Glp-1/glp-2 이중 효능제의 약학적 조성물 | |
| CN119285744A (zh) | 逆向-反转肽 | |
| CN105012936A (zh) | 抗菌肽bf-30在制备治疗或预防血栓性疾病药物中的应用 | |
| CN105079780B (zh) | 一种特异结合trb3的多肽在治疗腹主动脉瘤中的应用 | |
| US7425217B2 (en) | System and method for inhibiting cellular proliferation with tachykinins | |
| US8357653B2 (en) | System and method for inhibiting cellular proliferation with tachykinins | |
| WO2021243148A2 (en) | Methods and compositions for treating alcoholic liver disease | |
| US20230391841A1 (en) | Macrocyclic peptides | |
| US20060177417A1 (en) | Pharmaceutical formulations for sustained drug delivery |